Andrew H. Limper, MD, on Drug-Induced Lung Disease

In this podcast, Andrew H. Limper, MD, discusses new and emerging agents that may cause drug-induced lung disease, how classic toxicities of medications are presenting differently, and more.

Andrew H. Limper, MD, is professor of medicine and chair of the Division of Pulmonary and Critical Care Medicine at the Mayo Clinic in Rochester, Minnesota. 

Additional Reading:

• Leger P, Limper AH, Maldonado F. Pulmonary toxicities from conventional chemotherapy. Clin Chest Med. 2017;38(2):209-222. https://doi.org/10.1016/j.ccm.2017.01.002.